|
Suzanne brings over 18 years experience in international drug development to Activbiotics in both the large pharmaceutical and biopharma sectors. Suzanne has held senior positions with Glaxo Wellcome Canada in regulatory affairs and compliance, and with Ciba Canada as Acting VP, Research and Development, and Director, Regulatory Affairs and Pharmacoeconomics. Suzanne has an extensive background in both regulatory and clinical areas, and has been responsible for negotiating drug approvals for over 60 new chemical entities and drug products across a broad range of therapeutic areas. Suzanne was previously Vice-President of Clinical and Regulatory Affairs with Lorus Therapeutics, a Canadian-based biopharmaceutical company specializing in the development of cancer therapies. In this capacity, Ms. Cadden oversaw clinical and regulatory activities for international Phase I, II and III studies across several cancer programs in several countries | 